EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Metabolism and toxicity of aflatoxins M1 and B1 in human-derived in vitro systems



Metabolism and toxicity of aflatoxins M1 and B1 in human-derived in vitro systems



Toxicology and Applied Pharmacology 151(1): 152-158



Aflatoxin M1 (AFM1) is the principal hydroxylated aflatoxin metabolite present in the milk of dairy cows fed a diet contaminated with aflatoxin B1, (AFB1) and the metabolite is also present in the milk of human nursing mothers consuming foodstuffs containing the toxin. AFM1 is usually considered to be a detoxification product of AFB1 and this appears warranted if the biological endpoints involved are carcinogenicity and mutagenicity. However, it may not be a valid conclusion in the case of cytotoxicity. The metabolism of AFM1 and AFB, have been studied in vitro using human liver microsomes. Formation of primary metabolites associated with metabolic activation to the respective epoxides reflected the differences between the carcinogenic potentials of the two toxins and, similar to AFB1, the conjugation of AFM1 epoxide with reduced GSH was catalyzed by mouse, but not human liver cytosol. Although the majority of the binding of (3H)AFB1 to microsomal protein was dependent on metabolic activation, a high level of retention of (3H)AFM1 by microsomes, nonextractable in methanol and unrelated to metabolic activation, was observed. It appears possible that this property is related to the high cytotoxicity of AFM1. Experiments using human cell line cells either expressing or not expressing human cytochrome P450 enzymes in assays of acute toxicity (MTT assays) have demonstrated a directly toxic potential of AFM1 in the absence of metabolic activation, in contrast to AFB1. Caution therefore needs to be exercised in designating the formation of AFM1 as essentially detoxification when considering a biological response in which cytotoxicity may play a significant role, e.g., immunotoxicity.

(PDF same-day service: $19.90)

Accession: 003199461

Download citation: RISBibTeXText

PMID: 9705898

DOI: 10.1006/taap.1998.8440



Related references

Prenatal toxicity of aflatoxins: Application of mammalian cell culture systems to characterize the developmental toxicity of aflatoxins. Pennington Center nutrition series(1): 167-182, 1991

Carbamazepine: a 'blind' assessment of CVP-associated metabolism and interactions in human liver-derived in vitro systems. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 31(6): 321-343, 2001

An assessment of human liver-derived in vitro systems to predict the in vivo metabolism and clearance of almokalant. Drug Metabolism and Disposition: the Biological Fate of Chemicals 29(5): 712-720, 2001

Comparative studies on the cytochrome p450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems. Drug Metabolism and Disposition: the Biological Fate of Chemicals 31(9): 1093-1102, 2003

Aggregate culture of human embryonic stem cell-derived hepatocytes in suspension are an improved in vitro model for drug metabolism and toxicity testing. Toxicological Sciences 140(1): 236-245, 2015

Metabolism and toxicity of aflatoxins. Biological reactive intermediates II Chemical mechanisms and biological effects: 847-863, 1982

Metabolism and toxicity of aflatoxins. Advances in Experimental Medicine and Biology 136 Pt B: 847-863, 1981

In vitro human hepatocyte-based experimental systems for the evaluation of human drug metabolism, drug-drug interactions, and drug toxicity in drug development. Current Topics in Medicinal Chemistry 14(11): 1325-1338, 2015

Aflatoxins in aquatic species metabolism, toxicity and perspectives. Reviews In Fish Biology And Fisheries: 1, 99-130, 2008

SCI Pesticides Group Symposium: in-vitro systems for testing activity, toxicity and metabolism. Pesticide Science 35(3 ): 1-8, 1992

Human in vitro systems for toxicity testing Are they relevant?. Human & Experimental Toxicology 18(8): 508, 1999

Combined enhancement of microtubule assembly and glucose metabolism in neuronal systems in vitro: decreased sensitivity to copper toxicity. Biochemical and Biophysical Research Communications 264(2): 605-610, 1999

Further studies on the toxicity of the aflatoxins on human cell cultures. British Journal of Experimental Pathology 51(3): 314-316, 1970

Secondary metabolism related to the biosynthesis of aflatoxins and their congeners in vitro. International Botanical Congress Abstracts 17: 174, 1987